FDA Releases Updated RTA Checklist

The guidance replaces the 30 October 2017 draft guidance of the same name and describes the administrative steps will take to either Refuse to Accept (RTA) or file a request for an evaluation of automatic class III designation (De Novo request).

Read More:

Sign in to participate in the conversation

Server run by the main developers of the project 🐘 It is not focused on any particular niche interest - everyone is welcome as long as you follow our code of conduct!